Lung Cancer

September 16, 2015September 16, 2015

NIH Grants $2.6 Million to Joint Research Project to Develop Mathematical Model for Cell Autophagy in Lung Cancer

Lung Cancer, News

A diverse team of disease and research experts is developing a mathematical model that can predict and demonstrate autophagy in lung cancer, which can potentially be used in discovering and advancing ... Read more

September 14, 2015September 14, 2015

DelMar Pharmaceuticals Presents Planned Clinical Trial Protocol for Non-Small Cell Lung Cancer Therapy

Lung Cancer, News

DelMar Pharmaceuticals, Inc. a biopharmaceutical company that develops and commercializes new treatments for cancer, recently presented an outline of its planned clinical trial protocol for its lead drug candidate VAL-083 (dianhydrogalactitol) for ... Read more

September 8, 2015September 8, 2015

16th World Conference on Lung Cancer Hosts Presentations On Rociletinib Clinical Trial Results

Lung Cancer, News

A promising, new experimental therapy for lung cancer will be presented at this year’s 16th World Conference on Lung Cancer, which will be held between the 6th and 9th of September in Denver and hosted ... Read more

September 7, 2015September 7, 2015

US FDA Accepts Bristol-Myers Squibb’s sBLA for Opdivo (nivolumab) to Include Previously Treated Squamous NSCLC

Lung Cancer, News

The US Food and Drug Administration recently accepted Bristol-Myers Squibb Company’s supplemental Biologics License Application (sBLA) for Opdivo (nivolumab) for review as a treatment for previously treated patients with non-squamous (NSQ) non-small cell ... Read more

August 26, 2015August 27, 2015

New Drug Being Evaluated for Patients with Squamous Cell Cancer of the Lung

Lung Cancer, News

Boehringer Ingelheim recently announced that its product Giotrif/Gilotrif (generically known as afatinib) has been accepted for final review by the US Food and Drug Administration and the European Medicines Agency for the ... Read more

August 25, 2015August 25, 2015

DelMar Pharmaceuticals Will Present VAL-083 Lung Cancer Clinical Strategy

Lung Cancer, News

DelMar Pharmaceuticals, Inc., a biopharmaceutical firm focused on the advancement and commercialization of novel cancer therapies, recently announced it has been invited to present a clinical strategy overview concerning VAL-083 (dianhydrogalactitol) and its potential as a treatment for patients ... Read more

August 20, 2015August 21, 2015

American Lung Association & Inspire Working Together To Support Lung Cancer Patients

Lung Cancer, News

The American Lung Association is collaborating with Inspire’s online community to create a new digital resource for both caregivers and patients who have been affected by lung cancer. “The American Lung Association is committed to ... Read more

August 19, 2015August 19, 2015

Atezolizumab Immunotherapy Found To Decrease NSCLC Tumors

Lung Cancer, News

Genentech recently announced the results of a Phase II study entitled BIRCH for the investigational cancer immunotherapy atezolizumab (MPDL3280A; anti-PDL1). Primary endpoints for BIRCH study investigating the therapeutic benefit of atezolizumab in patients ... Read more

August 17, 2015August 18, 2015

Researchers Discover Better Way To Screen For Lung Cancer

Lung Cancer, News

Researchers at The Valley Hospital recently announced that they are working on paving the way for a much easier, accurate and less invasive method to screen for the most frequent type of lung cancer. Lung cancer is a ... Read more

August 14, 2015August 14, 2015

G1 Therapeutics Drug With Protective Effect Against Chemotherapy Tested in New Lung Cancer Clinical Trial

Lung Cancer, News

G1 Therapeutics, a clinical-stage company developing small-molecule based therapies for cancer patients, announced the initiation of two clinical trials testing their new therapy for protecting small-cell lung cancer patients undergoing chemotherapy. ... Read more